Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TILDRAKIZUMAB: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

42.5%
Female
57.5%
Male

Age Information

The average age of patients reporting adverse events with TILDRAKIZUMAB is 57.9 years.

Geographic Distribution

The majority of adverse event reports for TILDRAKIZUMAB originate from DE.

Report Summary & Outcomes

869
Total Reports
869
As Primary/Secondary Suspect
89
Deaths Reported
389
Hospitalizations
39
Life-Threatening
12
Disabilities

Reporting Timeline

First adverse event report: 20111102. Most recent report: 20250623. View full timeline →

More About TILDRAKIZUMAB

TILDRAKIZUMAB Full Profile Reports by Year Drug Interactions